Back to Results
First PageMeta Content
Neurochemistry / Dopamine receptor D2 / Pergolide / Dopaminergic / Lisuride / Cabergoline / Piribedil / Antiparkinson / Agonist / Dopamine agonists / Biology / Chemistry


[removed]-805–814$7.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics
Add to Reading List

Document Date: 2002-10-11 14:52:23

Open Document

File Size: 371,81 KB

Share Result on Facebook

City

Paris / Berlin / Indianapolis / Darmstadt / San Diego / Maidstone / /

Company

Griffon / MARK J. MILLAN / Ligand / GE / GraphPad Software / Packard Instrument Company Inc. / Pearson / Merck / Boehringer Ingelheim GmbH / Murrin LC / Schering / Eli Lilly & Co. / /

Country

Germany / France / United States / United Kingdom / /

Currency

USD / /

/

Event

Product Issues / /

Facility

Hall DA / /

IndustryTerm

treatment of Parkinson’s disease / /

MedicalCondition

L-DOPA-induced dyskinesias / catalepsy / dyskinesia / attenuated L-DOPA-induced dyskinesia / parkinsonism / disease / chronic treatment / hypothermia / mild cognitive impairment / dyskinesias / Parkinson’s disease / /

Organization

Servier Institut de Recherches / American Society for Pharmacology / Centre de Recherches de Croissy / IA IA / Institut de Recherches Servier / Society for Neuroscience / /

Person

Laetitia Marini / JEAN-PAUL NICOLAS / Carlo Erba / Arch Pharmacol / Ann Neurol / Anne Bonnard / FRED DE CEUNINCK / Christine Chaput / Filip V / DIDIER CUSSAC / Arch Psychiatry / VALERIE AUDINOT / Laurence Verrie`le / Nelly Fabry / /

Position

Kung MP / representative / receptor messenger / /

Product

HTC HD2 Smartphone / Pramipexole dihydrochloride / cabergoline / mice / /

ProvinceOrState

A.B. / Iowa / /

Technology

Neuroscience / hybridization / PKI / Cloning / /

URL

http /

SocialTag